Clarification regarding Extension of Annual General Meeting ('AGM') of Cian Healthcare Limited ('Company').
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare has informed the stock exchange that it could not hold its Annual General Meeting by the September 30, 2025 deadline because the Corporate Insolvency Resolution Process (CIRP) for its wholly-owned subsidiary, Dr. Smiths Biotech Private Limited, delayed the finalisation of consolidated accounts. The company attempted to file Form GNL-1 on the MCA portal to seek a 3-month extension, but the portal rejected the filing because the company is under CIRP. As an alternative, the company filed Form GNL-2 with the Registrar of Companies (RoC), Pune, explaining the difficulties and requesting extension until December 31, 2025. The RoC approved Form GNL-2, but since no formal extension order was generated, the company is treating the approval as a deemed extension to hold its AGM.
This signals ongoing financial distress and governance challenges for Cian Healthcare. The parent company and its subsidiary are both under CIRP, meaning shareholders' stakes are at significant risk, and the stock remains a high-risk investment with potential for value erosion under insolvency proceedings.